137 related articles for article (PubMed ID: 22986536)
1. Notch1 signaling contributes to the oncogenic effect of HBx on human hepatic cells.
Wang F; Xia X; Wang J; Sun Q; Luo J; Cheng B
Biotechnol Lett; 2013 Jan; 35(1):29-37. PubMed ID: 22986536
[TBL] [Abstract][Full Text] [Related]
2. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma.
Sun Q; Wang R; Wang Y; Luo J; Wang P; Cheng B
Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972
[TBL] [Abstract][Full Text] [Related]
3. The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells.
Luo J; Zhou H; Wang F; Xia X; Sun Q; Wang R; Cheng B
Int J Oncol; 2013 May; 42(5):1636-43. PubMed ID: 23450368
[TBL] [Abstract][Full Text] [Related]
4. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage.
Xu J; Yun X; Jiang J; Wei Y; Wu Y; Zhang W; Liu Y; Wang W; Wen Y; Gu J
Hepatology; 2010 Jul; 52(1):142-54. PubMed ID: 20578140
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.
Kongkavitoon P; Tangkijvanich P; Hirankarn N; Palaga T
PLoS One; 2016; 11(1):e0146696. PubMed ID: 26766040
[TBL] [Abstract][Full Text] [Related]
7. Notch1 promotes hepatitis B virus X protein-induced hepatocarcinogenesis via Wnt/β-catenin pathway.
Sun Q; Wang R; Luo J; Wang P; Xiong S; Liu M; Cheng B
Int J Oncol; 2014 Oct; 45(4):1638-48. PubMed ID: 25017705
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.
Gao J; Xiong Y; Wang Y; Wang Y; Zheng G; Xu H
Int J Oncol; 2016 Jan; 48(1):329-37. PubMed ID: 26530164
[TBL] [Abstract][Full Text] [Related]
9. Activated Notch signaling is required for hepatitis B virus X protein to promote proliferation and survival of human hepatic cells.
Wang F; Zhou H; Xia X; Sun Q; Wang Y; Cheng B
Cancer Lett; 2010 Dec; 298(1):64-73. PubMed ID: 20638778
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic knockdown of Notch1 inhibits hepatitis B virus X protein‑induced hepatocarcinogenesis of L02/HBx cells.
Peng Y; Zhou D; Ye Y; Kai C; Jiang Z; Zhu Z; Wu X; Xiong J
Oncol Rep; 2019 Feb; 41(2):1151-1159. PubMed ID: 30431136
[TBL] [Abstract][Full Text] [Related]
11. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.
Kong F; Hu W; Zhou K; Wei X; Kou Y; You H; Zheng K; Tang R
J Exp Clin Cancer Res; 2016 Nov; 35(1):172. PubMed ID: 27821177
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack.
Shan C; Zhang S; Cui W; You X; Kong G; Du Y; Qiu L; Ye L; Zhang X
Carcinogenesis; 2011 Aug; 32(8):1190-7. PubMed ID: 21665888
[TBL] [Abstract][Full Text] [Related]
14. Notch1 activation contributes to tumor cell growth and proliferation in human hepatocellular carcinoma HepG2 and SMMC7721 cells.
Gao J; Dong Y; Zhang B; Xiong Y; Xu W; Cheng Y; Dai M; Yu Z; Xu H; Zheng G
Int J Oncol; 2012 Nov; 41(5):1773-81. PubMed ID: 22922832
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
[TBL] [Abstract][Full Text] [Related]
16. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells.
Chan DW; Ng IO
J Pathol; 2006 Feb; 208(3):372-80. PubMed ID: 16353167
[TBL] [Abstract][Full Text] [Related]
17. Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma.
Liao B; Zhou H; Liang H; Li C
Int J Oncol; 2017 Nov; 51(5):1449-1459. PubMed ID: 29048612
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis B virus X promotes HepG2 cell cycle progression and growth via downregulation expression of p16 protein].
Mai L; Yang L; Kuang JY; Zhu JY; Kang YH; Zhang FC; Xie QF; Gao ZL
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):614-8. PubMed ID: 24119743
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
